Skip to main content

Table 1 Demographic, clinical, magnetic resonance imaging and self-reported and objective sleep characteristics

From: Insomnia, early and late rising are associated with small hippocampal volume and large white matter hyperintensity burden

Variables

n (%) or median (Q1-Q3)

Demographic and clinical characteristics (n = 678)

Sex

 

 Men

323 (47.64)

 Women

355 (52.36)

Age (years)

70.7 (67.8–74.0)

Educational level

 

 ≥ Primary

501 (73.89)

 < Primary

177 (26.11)

APOE ε4 carrier

 

 < 1 allele

539 (79.50)

 ≥ 1 allele

139 (20.50)

Alcohol (g/day)

 

 < 12

395 (59.58)

 [12;36[

189 (28.51)

 ≥ 36

79 (11.92)

History of cardiovascular diseases

 

 No

558 (82.42)

 Yes

119 (17.58)

Cardiovascular health score

8.0 (7.0–10.0)

Depressive status a

 

 No

484 (71.81)

 Yes

190 (28.19)

Sleeping pills b

 

 No

571 (84.22)

 Yes

107 (15.78)

MRI characteristics (n = 678)

 

Intracranial volume (cm3)

1190.2 (1115.9-1273.6)

Hippocampus volume (cm3)

5.8 (5.2–6.2)

Hippocampus volume (cm3)

 

 ≥ 5.4 (2nd and 3rd tertiles)

435 (68.2)

 < 5.4 (1st tertile)

203 (31.8)

White matter hyperintensities volume (cm3)

0.70 (0.30–2.70)

White matter hyperintensities volume (cm3)

 

 ≤ 1.6 (1st and 2nd tertiles)

455 (67.51)

 > 1.6 (3rd tertile)

219 (32.49)

Self-reported sleep characteristics (n = 678)

 

Nighttime sleep duration (h)

 

 ≤ 6

201 (31.41)

 ]6;9[

370 (57.81)

 ≥ 9

69 (10.78)

Napping

 

 No

355 (53.79)

 Infrequent/short

108 (16.36)

 Regular long

197 (29.85)

Sleep efficiency

 

 Good (≥ 85%)

315 (49.45)

 Poor (< 85%)

322 (50.55)

Bedtime

 

 ≤ 9 pm

37 (5.48)

 ]9–11[ pm

255 (37.78)

 ≥ 11 pm

383 (56.74)

Rising time

 

 ≤ 6 am

78 (11.56)

 ]6–8] am

492 (72.89)

 > 8 am

105 (15.56)

Excessive daytime sleepiness

 

 No

600 (90.91)

 Yes

60 (9.09)

Satisfaction in sleep quality

 

 Yes

500 (75.41)

 No

163 (24.59)

Number of insomnia symptoms

 

 0

196 (29.97)

 1

254 (38.84)

 2–3

204 (31.19)

Objective (via polysomnography) characteristics (n = 176)

Nighttime sleep duration (h)

6.1 (5.4–6.9)

N1 sleep duration (min)

22.5 (14.8–30.0)

% N1 sleep duration

6.0 (4.1–8.4)

N2 sleep duration (min)

227.8 (194.3-260.3)

% N2 sleep duration

61.9 (57.9–68.1)

N3 sleep duration (min)

39.8 (25.3–58.0)

% N3 sleep duration

11.4 (7.3–15.9)

REM sleep duration (min)

71.0 (54.8–85.0)

% REM sleep duration

19.3 (15.6–22.8)

SB duration (min)

27.3 (17.8–40.8)

SB NREM duration (min)

4.0 (2.5–7.3)

SB REM duration (min)

0.0 (0.0–4.0)

Sleep efficiency (%)

67.9 (60.6–75.6)

Sleep latency (min)

86.5 (64.5-134.8)

WASO (min)

173.8 (130.5-218.8)

AHI (/h)

4.0 (1.3–11.8)

iPLMS

23.3 (9.8–43.1)

O2 desaturation index > 3%

7.0 (3.0–15.0)

  1. Abbreviations AHI, apnea-hypopnea index; iPLMS, index of periodic leg movements during sleep; N1, stage 1; N2, stage 2; N3, stage 3; NREM, non-rapid eye movement; REM, rapid eye movement; SB, sleep bout; WASO, wake after sleep onset
  2. a Center for Epidemiological Studies-Depression Scale ≥ 16 or current antidepressant treatment
  3. b including benzodiazepine, benzodiazepine like compounds and miscellaneous medications